GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adventa Bhd (XKLS:7191) » Definitions » Price-to-Free-Cash-Flow

Adventa Bhd (XKLS:7191) Price-to-Free-Cash-Flow : N/A (As of Jun. 06, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Adventa Bhd Price-to-Free-Cash-Flow?

As of today (2024-06-06), Adventa Bhd's share price is RM0.32. Adventa Bhd's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was RM-0.07. Hence, Adventa Bhd's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Adventa Bhd's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Adventa Bhd's highest Price-to-Free-Cash-Flow Ratio was 104.57. The lowest was 4.92. And the median was 14.38.

XKLS:7191's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.48
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Adventa Bhd's Free Cash Flow per Share for the three months ended in Mar. 2024 was RM-0.04. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was RM-0.07.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -14.50% per year.

During the past 13 years, Adventa Bhd's highest 3-Year average Free Cash Flow per Share Growth Rate was 48.90% per year. The lowest was -211.90% per year. And the median was -28.70% per year.


Adventa Bhd Price-to-Free-Cash-Flow Historical Data

The historical data trend for Adventa Bhd's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adventa Bhd Price-to-Free-Cash-Flow Chart

Adventa Bhd Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Adventa Bhd Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Adventa Bhd's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Adventa Bhd's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adventa Bhd's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's Price-to-Free-Cash-Flow falls into.



Adventa Bhd Price-to-Free-Cash-Flow Calculation

Adventa Bhd's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.32/-0.072
=N/A

Adventa Bhd's Share Price of today is RM0.32.
Adventa Bhd's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Adventa Bhd  (XKLS:7191) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Adventa Bhd Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Adventa Bhd's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Adventa Bhd (XKLS:7191) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centres, and pharmacies. Previously, it also included the renal dialysis business which are both for home and centre-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of revenue from Malaysia.

Adventa Bhd (XKLS:7191) Headlines

No Headlines